TOOLS QUESTION ATTACHMET Question 46 FLA QUESTION In which one of the following situations would use of the human capital method for valuing indirect benefits be MOST useful? Question #46 attachmer 2 pages Currently selected: 45 A Calculating the cost of two drugs used to control blood pressure in patients with hypertension that live in a City versus a more rural area Pharmacoeco So Discount ICER - DU B Estimating the probability of achieving a cure in patients with advanced stages of lung cancer that have not responded to first-line therapy 47 Netcost Totalco o Net benefit Tota 8 C Determining the monetary value of lost work time avoided by an accountant who must receive weekly injections from a clinic an hour away from his home to treat rheumatoid arthritis Benefit-to Cost-to- DA Mensuring the impact of a drug to control blood sugar in a patient with diabetes Cost-effectivene QUESTIONS VERSION ZW46 CU FLAG QUESTION 19 Question 22 Which one of the following BEST explains the advantage of using incremental net benefit (INB) calculations over incremental cost effectiveness ratio (CER)? Question w22 attache 2 pages 20 Currently selected 21 Pharmace A B evaluates data in a nonlinear progression that reduces risk of error Disco 22 ICER BIN bypasses the need for dollar values attached to costs 23 Netcost Ter Net benefit 24 CIB integrates the value of health outcomes in the comparison of interventions Benef 25 Cost- D INB avoids the need to determine direct medical costs 26 Cost-effe 22 OF 50 QUESTIONS VERSION 246 Prey Question 23 ... FLAG OUESTION in which one of the following situations would use of pharmacoeconomic analysis be MOST useful? Currently selected :D Question 23 attachment 2 pages A Discover new drugs to treat diabetes Pharmacoeconomic Spring 2 B Compare the pharmacokinetics of both metformin and dulaglutide in diabetic patients with renal insufficiency Discount factor Difere ICER- Di Tereng Netcost Total costs -T 23 C Assess the adverse effect profiles of using metformin and dulaglutide alone or in combination in patients with diabetes and heart failure Net benefit Total benef Benefit-to-cost 25 Cost-to-benefit Drauate the cost effectiveness of using either metformin or dulaglutide to prevent disease-associated complications in patients with diabetes 26 Cost-effectiveness rati 50 QUESTIONS VERSION W46 CLOSET Promi